MEDANA, Claudio
 Distribuzione geografica
Continente #
EU - Europa 128
NA - Nord America 114
AS - Asia 32
Totale 274
Nazione #
US - Stati Uniti d'America 113
IE - Irlanda 56
SE - Svezia 28
DE - Germania 19
HK - Hong Kong 14
UA - Ucraina 14
CN - Cina 8
IT - Italia 7
SG - Singapore 7
BE - Belgio 3
CA - Canada 1
FR - Francia 1
IR - Iran 1
TR - Turchia 1
VN - Vietnam 1
Totale 274
Città #
Dublin 56
Jacksonville 27
Dearborn 16
Hong Kong 14
Ann Arbor 13
Bremen 6
Lawrence 6
Princeton 6
San Mateo 6
Singapore 6
Wilmington 5
Beijing 3
Boardman 3
Brussels 3
Ashburn 2
Villa Guardia 2
Fuzhou 1
Ho Chi Minh City 1
Houston 1
Kocaeli 1
Kunming 1
Milan 1
Munich 1
Mülheim 1
Nanjing 1
Norwalk 1
Piemonte 1
Quzhou 1
San Diego 1
Torino 1
Toronto 1
Trecate 1
Zanjan 1
Totale 191
Nome #
Advanced Glycation End Products Inhibition Restores Sphingolipid Rheostat in Mice Liver and Prevents Diet-Induced Insulin Resistance 68
Chronic administration of saturated fats and fructose differently affect SREBP activity resulting in different modulation of Nrf2 and Nlrp3 inflammasome pathways in mice liver 44
Fructose-derived advanced glycation end-products drive lipogenesis and skeletal muscle reprogramming via SREBP-1c dysregulation in mice 44
Multi-target detection of egg-white and pig gelatin fining agents in Nebbiolo-based aged red wine by means of nanoHPLC-HRMS 44
Fructose-derived advanced glycation end-products induce a negative crosstalk between lipogenesis and muscle reprogramming in mice through SREBP-1c 41
Targeted and untargeted quantification of quorum sensing signalling molecules in bacterial cultures and biological samples via HPLC-TQ MS techniques 27
Solar photodegradation of irinotecan in water: optimization and robustness studies by experimental design 16
Totale 284
Categoria #
all - tutte 1.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202054 4 0 4 2 8 11 12 1 5 3 4 0
2020/202142 5 0 4 2 4 0 9 0 7 5 6 0
2021/202236 1 1 6 8 1 1 1 0 3 2 4 8
2022/202398 12 5 4 3 6 6 1 6 50 0 3 2
2023/202453 2 1 8 3 12 0 8 2 0 0 8 9
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 284